Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 6/20 | 0.50 |
| ▸ | VNN1 | O95497 | 6/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.42 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.42 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.41 |
| ▸ | CDK2 | P24941 | 4/20 | 0.41 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13118906 | 0.90 | GSK3B (0.65) | GSK3BCCNE1CDK2 | |
| SCHEMBL14418687 | 0.88 | GSK3B (0.56) | GSK3BVNN1CHEK1CCNE1CDK2 | |
| SCHEMBL13119171 | 0.82 | GSK3B (0.62) | GSK3BCCNE1CDK2 | |
| SCHEMBL14545243 | 0.81 | GSK3B (0.57) | GSK3BCHEK1CCNE1CDK2 | |
| SCHEMBL13288641 | 0.80 | GSK3B (0.53) | GSK3BCHEK1CCNE1CDK2 | |
| SCHEMBL13288736 | 0.79 | GSK3B (0.53) | GSK3BCHEK1CCNE1CDK2 | |
| SCHEMBL13118934 | 0.78 | GSK3B (0.70) | GSK3BCCNE1CDK2 | |
| SCHEMBL13288716 | 0.78 | GSK3B (0.52) | GSK3BCHEK1CCNE1CDK2 | |
| SCHEMBL14545821 | 0.78 | GSK3B (0.53) | GSK3BCHEK1CCNE1CDK2 | |
| SCHEMBL12953895 | 0.77 | GSK3B (0.51) | GSK3BCHEK1CCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2194058-A1 | Pyrazolopyrimidines suitable for the treatment of cancer diseases | SCHERING CORPORATION (US) | 2010-06-09 | — | — | EP | disclosed |